Lexaria Bioscience Corp. stock is up 24.81% since 30 days ago. The next earnings date is Jan 16, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 17 November’s closed higher than October.
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x.